From Yahoo Finance: 2024-04-27 08:58:00

Nvidia holds a $100 million portfolio of AI stocks, concentrated in just five companies with 97% invested in two main holdings namely ARM Holdings and Recursion Pharmaceuticals. Recursion uses AI to accelerate drug discovery, with five treatments in phase 2 clinical trials aiming to serve rare diseases and specific cancers. While risky, Recursion’s potential payoff could be significant, with revenue growing to $44 million last year. For investors considering Recursion, it’s crucial to weigh the risks and benefits before making an investment decision. Nvidia’s AI investment strategy, backed by Cathie Wood’s Ark Invest, continues to show promise in this innovative sector.



Read more at Yahoo Finance: Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves